Healthcare

Contraceptives Market is Expected to be Worth US$ 37,242.7 Mn By 2025

The demand within the global market for contraceptives has been rising on account of the growing incidence of sexually transmitted diseases, finds Transparency Market Research (TMR). The competitive dynamics of the global market for contraceptives have drastically changed over the past decade. The key players have resorted to informative marketing practices in order to create a regular consumer base. There is a high possibility of new business practices coming to the fore of the global contraceptives market. Moreover, the presence of established vendors in the global market for contraceptives is a key consideration for newbie vendors as well.

It is expected that strategic alliances amongst large, medium, and small-scale vendors would be a common trend in the global contraceptives years to come. This will help the larger vendors in accessing the regional markets, while the smaller vendors could learn from the strategies of the established vendors. Furthermore, mergers and acquisitions are also projected to be a key trend in the global contraceptives market in the years to come.

Request a Sample of Cell Culture Market Report

Transparency Market Research (TMR) finds that the global contraceptives market would expand at a healthy CAGR of 6.10% over the period between 2017 and 2025. The cumulative value of the global contraceptives market would reach US$ 37,242.7 mn by 2025-end, rising up from a value of US$ 22,050 mn in 2016. On the basis of product, the demand for oral contraceptives is on a rise in recent times. Based on geography, the market for contraceptive in North America is expanding at a stellar pace due to growing awareness about STDs in the US and Canada

The review is based on TMR’s review titled, “Contraceptives Market (Product – Contraceptive Drugs (Oral Contraceptives (Combined Contraceptives and Mini-pills), Contraceptive Injectable, and Topical Contraceptive Patch) and Contraceptive Devices (Male Contraceptive Devices and Female Contraceptive Devices (Female Condoms, Contraceptive Diaphragms, Contraceptive Sponges, Contraceptive Vaginal Rings, Intrauterine Devices, Sub-dermal Contraceptive Implants, Non-surgical Permanent Contraception Devices)); Distribution Channel – Hospital Pharmacy (Public and Private), Independent Pharmacy, Online Platform, and Clinics) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”.

Tags

Related Articles

Close